Search
for

    Learn

    0 / 0 results
    — no results

    Research

    5 / 911 results

    Community Join

    5 / 43 results

      community [Theory] Big Bald is deliberately delaying the cure indefinitely

      in Satire  343 upvotes 6 months ago
      The conversation humorously suggests that the hair loss industry, referred to as "Big Bald," deliberately delays a cure to profit from ongoing treatments like minoxidil, finasteride, and dutasteride. Participants debate whether a cure would be more profitable than current treatments, with some suggesting that the industry prefers continuous treatments for sustained profit.

      community PP405 Update and My Take on Pelage

      in Research/Science  85 upvotes 4 months ago
      Pelage Pharmaceuticals raised $120M for their hair loss treatment, PP405, showing strong investor confidence despite limited data. There is skepticism about its efficacy and long-term effects compared to treatments like GT20029.

      community PYRILUTAMIDE PHASE 3 RESULTS : No statistical significance

      in Research/Science  126 upvotes 2 years ago
      The phase 3 trial results for Pyrilutamide showed no significant difference from the control treatment in increasing hair count, leading to the company halting its development. Users discussed their disappointment and skepticism about hair loss treatments, with some mentioning other treatments like Minoxidil, Finasteride, and RU58841.

      community 4 month progress (delayed start)

      in Progress Pictures  765 upvotes 1 year ago
      The user has been using Minoxidil for 3.5 months, Finasteride for 3 months, derma rolling twice a week, taking Saw Palmetto daily, and using Rosemary Shampoo to treat hair loss, and is happy with the progress despite some remaining hair loss at one temple. They encourage others to start treatment early if hair loss affects their confidence, and they use a 5% Minoxidil solution and take 2.5mg of Finasteride three times a week.

      community Prediction: Scube3 is never coming out

      in Research/Science  6 upvotes 2 years ago
      Scube3, a potential hair loss treatment, is unlikely to be released because it was given to a startup company, Amplifica, which may go bankrupt and fail to bring the treatment to market. Amplifica is prioritizing other treatments over Scube3, which could lead to financial loss and the end of Scube3's development.